CHE Chemed Corporation

VITAS HEALTHCARE BREAKS GROUND ON SECOND INPATIENT HOSPICE UNIT IN DALLAS, TEXAS

VITAS HEALTHCARE BREAKS GROUND ON SECOND INPATIENT HOSPICE UNIT IN DALLAS, TEXAS

The New Facility at Methodist Dallas Medical Center will Serve Terminally Ill Patients Located in Dallas’ Southern Sector

Dallas, TX, July 10, 2018 (GLOBE NEWSWIRE) -- VITAS Healthcare, the nation’s leading provider of end-of-life care, has broken ground on a new Inpatient Hospice Unit (IPU) at Methodist Dallas Medical Center, caring for patients in 14 area counties. VITAS currently operates 28 IPUs nationwide and this will be VITAS’ third IPU in the Dallas and Fort Worth markets. The existing facilities are at in Carrollton and at in Fort Worth. The new VITAS IPU, expected to be completed in early 2019, is located at 1441 North Beckley Avenue in Dallas.

Hospice IPUs, like the Dallas facility, enable whose symptoms have become unmanageable in their home-care setting while adhering to the patient’s wishes for end of life care. VITAS leads the way in the development of hospice and palliative care to improve the quality of life for patients and their families.

“We are thrilled to expand our presence in the Dallas/Fort Worth area, and to be able to better serve patients and families in the southern sector,” said Marilyn Conley, general manager of VITAS Healthcare of Dallas. “We look forward to providing more patients with the unique care they require while helping them feel like they are in the comfort of their own home.”

The 13,000 square foot IPU is a $2.8 million renovation on the fifth floor of Schenkel Tower at Methodist Dallas Medical Center. Expected to serve more than 800 patients each year, the IPU will have 16 private patient rooms as well as family rooms, a children’s room, a quiet room, kitchen amenities and overnight accommodations for family members. It will also be equipped with support spaces where interdisciplinary teams of physicians, nurses, hospice aides, social workers, chaplains, volunteers and bereavement support staff members can attend to the medical, emotional, social and spiritual needs of patients and their families.

All hospice-appropriate patients will benefit from VITAS’ unique care model ensuring that only nurses provide hands-on, compassionate care at the bedside. VITAS also offers a wide range of holistic services to enhance the quality of life for patients and families including massage therapy, music therapy, pet therapy, veterans program and memory bears, as well as access to a full-time child bereavement specialist and full-time respiratory therapist.

For more information about , visit VITAS.com or call 214.424.5600.

 

About VITAS Healthcare   

2018 marks the 40th anniversary of VITAS Healthcare, a pioneer and leader in the American hospice movement. Headquartered in Miami, Florida, VITAS (pronounced VEE-tahs) operates 45 hospice programs in 14 states (California, Connecticut, Delaware, Florida, Georgia, Illinois, Kansas, Missouri, New Jersey, Ohio, Pennsylvania, Texas, Virginia and Wisconsin) and the District of Columbia. VITAS employs 11,765 professionals who care for terminally ill patients daily, primarily in the patients’ homes, and also in the company’s 28 inpatient hospice units as well as in hospitals, nursing homes and assisted living communities/residential care facilities for the elderly. At the conclusion of the first quarter of 2018, VITAS reported an average daily census of 17,380. Visit .

 

###

Attachments

Claudia Quintana
VITAS Healthcare
877-848-2701
 
EN
10/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Chemed Corporation

 PRESS RELEASE

Chemed Reports Fourth-Quarter 2025 Results

Chemed Reports Fourth-Quarter 2025 Results CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period. Results for Quarter Ended December 31, 2025 Consolidated operating results: Revenue was $639.3 million, essentially flat with the...

 PRESS RELEASE

Chemed Corporation Board of Directors Authorizes an Additional $300 Mi...

Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed’s existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash divide...

 PRESS RELEASE

Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Con...

Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26 CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 26, 2026, to discuss the company's quarterly results and to provide an update on its business. Participants may access a li...

 PRESS RELEASE

Chemed Corporation to Present at the BofA Securities 2025 Virtual Home...

Chemed Corporation to Present at the BofA Securities 2025 Virtual Home Care Conference CINCINNATI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025, at 1:20 PM (ET). The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York S...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch